Privia Health Group, Inc. Increase (Decrease) in Accounts Payable
Privia Health Group, Inc. (PRVA) reported Increase (Decrease) in Accounts Payable of -$5.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- Privia Health Group, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $10.46M, a 69.64% increase year-over-year.
- Privia Health Group, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$16.25M.
- Privia Health Group, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $12.14M, a 0.39% increase year-over-year.
- Privia Health Group, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $10.37M, a 114.99% increase year-over-year.
- Privia Health Group, Inc. increase (decrease) in accounts payable for fiscal 2025 was $14.82M, a 25.53% decline from fiscal 2024.
- Privia Health Group, Inc. increase (decrease) in accounts payable for fiscal 2024 was $19.91M, a 298.58% increase from fiscal 2023.
- Privia Health Group, Inc. increase (decrease) in accounts payable for fiscal 2023 was $4.99M, a 27.12% decline from fiscal 2022.
- Privia Health Group, Inc. increase (decrease) in accounts payable for fiscal 2022 was $6.85M, a 442.95% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$5.79M 10-Q · filed 2026-08-06 | $6.35M derived: sum of 3 quarters · filed 2026-08-06 | $16.72M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$16.25M 10-Q · filed 2026-05-07 | -$4.11M derived: sum of 2 quarters · filed 2026-05-07 | $6.26M derived: sum of 3 quarters · filed 2026-05-07 | $12.43M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $12.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.51M derived: sum of 2 quarters · filed 2026-02-27 | $28.67M derived: sum of 3 quarters · filed 2026-08-06 | $14.82M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $10.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $16.53M derived: sum of 2 quarters · filed 2026-08-06 | $2.68M 10-Q · filed 2025-11-06 | $14.78M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $6.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$7.69M 10-Q · filed 2026-08-06 | $4.41M derived: sum of 3 quarters · filed 2026-08-06 | $9.23M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$13.85M 10-Q · filed 2026-05-07 | -$1.75M derived: sum of 2 quarters · filed 2026-05-07 | $3.07M derived: sum of 3 quarters · filed 2026-05-07 | $13.23M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $16.92M derived: sum of 2 quarters · filed 2026-02-27 | $27.09M derived: sum of 3 quarters · filed 2026-02-27 | $19.91M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $4.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $14.99M derived: sum of 2 quarters · filed 2025-11-06 | $7.81M 10-Q · filed 2025-11-06 | $11.31M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-06-30 | $10.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.99M 10-Q · filed 2025-08-07 | $6.49M derived: sum of 3 quarters · filed 2026-02-27 | $11.95M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-03-31 | -$7.18M 10-Q · filed 2025-05-08 | -$3.67M derived: sum of 2 quarters · filed 2026-02-27 | $1.78M derived: sum of 3 quarters · filed 2026-02-27 | $4.35M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.96M derived: sum of 2 quarters · filed 2026-02-27 | $11.53M derived: sum of 3 quarters · filed 2026-02-27 | $4.99M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $8.03M derived: sum of 2 quarters · filed 2024-11-07 | $1.49M 10-Q · filed 2024-11-07 | $7.07M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.97M 10-Q · filed 2024-08-08 | $1.62M derived: sum of 3 quarters · filed 2025-02-27 | $8.54M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | -$6.54M 10-Q · filed 2024-05-09 | -$953.00K derived: sum of 2 quarters · filed 2025-02-27 | $5.97M derived: sum of 3 quarters · filed 2025-02-27 | $2.06M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $12.50M derived: sum of 2 quarters · filed 2025-02-27 | $8.59M derived: sum of 3 quarters · filed 2025-02-27 | $6.85M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $6.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $3.01M derived: sum of 2 quarters · filed 2023-11-03 | $1.27M 10-Q · filed 2023-11-03 | $2.71M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-06-30 | -$3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$5.65M 10-Q · filed 2023-08-03 | -$4.21M derived: sum of 3 quarters · filed 2024-02-27 | $2.17M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | -$1.74M 10-Q · filed 2023-05-04 | -$304.00K derived: sum of 2 quarters · filed 2024-02-27 | $6.07M derived: sum of 3 quarters · filed 2024-02-27 | $8.38M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $7.82M derived: sum of 2 quarters · filed 2024-02-27 | $10.12M derived: sum of 3 quarters · filed 2024-02-27 | $1.26M 10-K · filed 2024-02-27 | |||
| 2021-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $8.68M derived: sum of 2 quarters · filed 2022-11-10 | -$176.00K 10-Q · filed 2022-11-10 | -$2.06M 10-Q · filed 2021-11-08 | |||
| 2021-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$6.55M 10-Q · filed 2022-08-11 | -$810.00K 10-Q · filed 2021-08-09 | ||||
| 2021-03-31 | -$8.86M 10-Q · filed 2022-05-12 | -$1.52M 10-Q · filed 2021-05-28 | |||||
| 2020-09-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$1.49M derived: sum of 2 quarters · filed 2021-11-08 | $2.46M 10-Q · filed 2021-11-08 | ||||
| 2020-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $2.36M 10-Q · filed 2021-08-09 | |||||
| 2020-03-31 | $3.95M 10-Q · filed 2021-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |